Van Stiegmann G
Surg Annu. 1991;23 Pt 1:175-202.
Endoscopic treatment is widely accepted for both initial and subsequent definitive therapy in patients with hemorrhage from esophageal varices. Endoscopic sclerotherapy, once performed with rigid endoscopes in anesthetized patients, is now performed with flexible endoscopes in awake patients, who frequently return home immediately after the procedure. Such treatment does not confer a survival advantage in the early period after variceal hemorrhage, but serial treatment does result in a lower risk of recurrent hemorrhage and probably prolongs life. Primary treatment by endoscopic sclerotherapy appears to be equal or more effective than primary shunt therapy, even with a sclerotherapy failure rate of from 10 to 30 percent. In spite of such results, the incidence of rebleeding and treatment-related complications and the mortality among sclerotherapy-treated patients remain high. Newer forms of endoscopic treatment such as polymer injection and mechanical ligation have emerged in attempts to better the results obtained with sclerotherapy. Refinement of the technique for conventional sclerotherapy and the potential for increased effectiveness of the new techniques may yet result in improved and safer endoscopic therapy for bleeding esophageal varices.
内镜治疗在食管静脉曲张出血患者的初始治疗和后续确定性治疗中均被广泛接受。内镜硬化疗法,曾经是在麻醉患者中使用硬式内镜进行,现在则是在清醒患者中使用软式内镜进行,这些患者术后通常可立即回家。这种治疗在静脉曲张出血后的早期并不会带来生存优势,但连续治疗确实能降低再出血风险,并可能延长生命。内镜硬化疗法的初始治疗似乎与初始分流疗法效果相当或更有效,即便硬化疗法的失败率为10%至30%。尽管有这样的结果,但硬化疗法治疗患者的再出血发生率、治疗相关并发症及死亡率仍然很高。诸如聚合物注射和机械结扎等更新的内镜治疗形式已出现,旨在改善硬化疗法的治疗效果。传统硬化疗法技术的改进以及新技术有效性提高的潜力,可能会带来更安全有效的内镜治疗食管静脉曲张出血的方法。